Comparing Complete Remission After Treatment With Selumetinib/Placebo in Patient With Differentiated Thyroid Cancer
Status:
Terminated
Trial end date:
2019-03-06
Target enrollment:
Participant gender:
Summary
The study is designed to evaluate the clinical efficacy, safety and tolerability of
selumetinib with radioactive iodine therapy in patients with differentiated thyroid cancer.